Results 151 to 160 of about 235,487 (237)
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi +10 more
wiley +1 more source
Differences in Opioid Prescribing by Urban and Rural Pharmacists in Nova Scotia, Canada-A Time Series Analysis from 2018 to 2022. [PDF]
Chisholm E, Zhang Y, Sanyal C.
europepmc +1 more source
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary +21 more
wiley +1 more source
Medical superintelligence: foundations and aspirations. [PDF]
Liu X +13 more
europepmc +1 more source
Objective We examined associations of posttraumatic stress disorder (PTSD) and other mental health disorders (OMH) with rheumatoid arthritis (RA), accounting for effects of smoking. Methods We conducted a matched case‐control study, identifying incident RA cases and controls using national Veterans Health Administration data (2006–2019).
Kelsey Coziahr +15 more
wiley +1 more source
Respecting the right to refuse: is decision-making capacity disproportionately challenged in patients declining medical care in order to treat? [PDF]
Angelova Y +4 more
europepmc +1 more source
Generative AI in clinical practice: how should rheumatologists evaluate and monitor emerging tools?
Generative artificial intelligence (AI) is increasingly being used in rheumatology practice, to assist with tasks such as documentation, record summarization, and clinical decision support. Rheumatologists need a practical approach to determining what evidence and oversight each application requires.
Koushan Kouranloo +2 more
wiley +1 more source
Split-gas biogenic methane accounting: policy design, transparency, and international coordination. [PDF]
Jones M, Jolly N, Petre R.
europepmc +1 more source

